S2Medical AB raises SEK 2.9 million via prefunded share issue
The issue was oversubscribed by approximately 123 percent. Trading in B-shares is expected to start in week 41.
See the latest news and media coverage for S2Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing wound care solutions
s2m.seLast updated
In short: S2Medical reported a return to positive operating profit in early 2026, conducted several rights issues, and secured European patents.
The issue was oversubscribed by approximately 123 percent. Trading in B-shares is expected to start in week 41.
The company reports on the subscription period and trading of rights running between August and September 2026. Shareholders are urged to follow their custodians' instructions to participate in the issue.
The subscription period runs from August 24 to September 10, 2026, with detailed instructions available on the company website.
Revenue rose to SEK 7.4 million and the operating result turned positive. The company conducted new share issues and validated a European patent.
S2Medical AB has published its financial results for the half-year ended June 30, 2026. For this half-year, the company recorded revenue...
H. Lundbeck A/S (HLBBF) Q2 2026 Earnings Call August 19, 2026 7:00 AM EDTCompany ParticipantsCharl van Zyl - President & CEOThomas Gibbs - Executive VP...
* S2MEDICAL AB (PUBL) HAS RECEIVED A RECORD ORDER FOR MEDICAL CONSUMABLES INTENDED TO COUNTER THE SPREAD OF COVID-19 * S2MEDICAL AB (PUBL) - ORDER...
S2Medical AB (publ) has received a new order for medical consumables intended to counteract the spread of COVID-19. The order value is approx 3 700 000 SEK with...
Track S2Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to S2Medical and other trending companies.